Evolent Health Inc. (EVH)
NYSE · Healthcare
Evolent Health Inc. EBITDA 2020–2025
Evolent Health Inc. annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Evolent Health Inc. ebitda for the quarter ending March 31, 2026 was 12.7 M.
- Evolent Health Inc. ebitda for the twelve months ending March 31, 2026 was 82.6 M.
- Evolent Health Inc. annual ebitda for 2025 was 85.0 M, a 20.15% decrease from 2024.
- Evolent Health Inc. annual ebitda for 2024 was 106.5 M, a 129.56% increase from 2023.
- Evolent Health Inc. annual ebitda for 2023 was 46.4 M, a 530.18% increase from 2022.
- Evolent Health Inc. annual ebitda for 2022 was 7.4 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
Evolent Health Inc. EBITDA — FAQ
Evolent Health Inc. (EVH) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EVH's ebitda history?
The chart and table above show Evolent Health Inc.'s ebitda by year and by quarter, including the growth rate.